GC2008

N/A

Report date: 2022/11/17 17:33:26

Base Information

Drug NameGC2008
Drug Alias NameGC-2008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-TGF-β
TargetsTransforming growth factor beta
Therapy Area/IndicationsOsteogenesis Imperfecta
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsOsteogenesis Imperfecta
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A